WIPO logo
Мобильная версия | Deutsch | English | Español | Français | 日本語 | 한국어 | Português | 中文 | العربية |
PATENTSCOPE

Поиск по международным и национальным патентным фондам
World Intellectual Property Organization
Поиск
 
Просмотреть
 
Перевод
 
Настройки
 
Новости
 
Войти в систему
 
Помощь
 
Автоматизированный перевод
1. (WO2016140527) COMPOSITION FOR PREVENTING, IMPROVING OR TREATING NEUROLOGICAL DISORDERS, CONTAINING OSMOTIN PEPTIDE AS ACTIVE INGREDIENT
Новейшие библиограф. данные, касающиеся досье в Международном бюро   

TranslationПеревести: оригинал-->русский
№ публикации:    WO/2016/140527    № международной заявки:    PCT/KR2016/002123
Дата публикации: 09.09.2016 Дата международной подачи: 03.03.2016
МПК:
A23L 1/305 (2006.01), A23L 1/00 (2006.01)
Заявители: INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY [KR/KR]; 501, Jinju-daero Jinju-si Gyeongsangnam-do 52828 (KR)
Изобретатели: KIM, Myeong Ok; (KR)
Агент: CHOI, Kyu Whan; (KR)
Дата приоритета:
10-2015-0030455 04.03.2015 KR
Название (EN) COMPOSITION FOR PREVENTING, IMPROVING OR TREATING NEUROLOGICAL DISORDERS, CONTAINING OSMOTIN PEPTIDE AS ACTIVE INGREDIENT
(FR) COMPOSITION POUR PRÉVENIR, AMÉLIORER OU TRAITER DES TROUBLES NEUROLOGIQUES, CONTENANT UN PEPTIDE D'OSMOTINE COMME PRINCIPE ACTIF
(KO) 오스모틴 펩티드를 유효성분으로 함유하는 신경질환의 예방, 개선 또는 치료용 조성물
Реферат: front page image
(EN)The present invention relates to a composition for preventing, improving or treating neurological disorders, containing an osmotin peptide as an active ingredient. Specifically, the osmotin peptide is an osmotin peptide consisting of nine amino acids; when the osmotin peptide is treated, the growth rate of neurons increases, there is almost no cytotoxicity, and apoptosis is inhibited; and when being administered to an animal model, the osmotin peptide penetrates through the hippocampus of the brain, the cerebral cortex, and the hypothalamus, which is a deep part of the brain, and thus the osmotin peptide can be usefully used as a composition for preventing, improving or treating neurological disorders.
(FR)La présente invention concerne une composition pour prévenir, améliorer ou traiter des troubles neurologiques, contenant un peptide d'osmotine comme principe actif. Spécifiquement, le peptide d'osmotine est un peptide d'osmotine constitué de neuf acides aminés ; lorsque le peptide d'osmotine est traité, la vitesse de croissance de neurones augmente, il n'y a pratiquement aucune cytotoxicité, et l'apoptose est inhibée ; et, lorsqu'il est administré à un modèle animal, le peptide d'osmotine pénètre à travers l'hippocampe du cerveau, le cortex cérébral et l'hypothalamus, qui est une partie profonde du cerveau, et, par conséquent, le peptide d'osmotine peut être utilisé avantageusement comme composition pour prévenir, améliorer ou traiter des troubles neurologiques.
(KO)본 발명은 오스모틴 펩티드를 유효성분으로 함유하는 신경질환의 예방, 개선 또는 치료용 조성물에 관한 것이다. 상세하게는 상기 오스모틴 펩티드는 9개의 아미노산으로 이루어진 오스모틴 펩티드이며, 오스모틴 펩티드를 처리하는 경우, 신경세포의 성장률이 증가하고, 세포 독성은 거의 없으며, 세포사멸을 억제하였고, 동물모델에 투여하여, 뇌의 해마, 대뇌피질, 뇌의 심부인 시상하부까지 상기 오스모틴 펩티드가 침투하므로 신경질환의 예방, 개선 또는 치료용 조성물로 유용하게 이용될 수 있다.
Указанные государства: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Язык публикации: Korean (KO)
Язык подачи: Korean (KO)